comparemela.com

Latest Breaking News On - Bivictrix therapeutics - Page 2 : comparemela.com

BiVictriX round table highlights lead assets potential in AML

BiVictriX round table highlights lead assets potential in AML
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Colorado
United-states
Texas
University-of-colorado-school-medicine
Md-anderson-cancer-center
Christie
Drug-administration
Bivictrix-therapeutics
Cancer-center

Bivictrix selects final sequences for lead tumour programme

Bivictrix Therapeutics PLC - Macclesfield, England-based biotechnology company focused on cancer therapies - Says final sequences have been selected for its second programme BVX002, an antibody drug.

Emma-curzon
Alliance-news
Bivictrix-therapeutics
Alliance-news-ltd
Executive-officer-tiffany-thorn
Acute-myeloid-leukaemia
All-rights
Markets

BiVictriX patent boost; 4Global deal extended

The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Bivictrix Therapeutics PLC - Macclesfield, England-based.

United-kingdom
Aughrim
Wicklow
Ireland
Botswana
Tullow
Carlow
Orinduik
Potaro-siparuni
Guyana
Japan
South-africa

BiVictriX gets patent for its lead asset in Japan

BiVictriX Therapeutics has received a patent grant from the Japanese Patent Office (JPO) for its lead asset BVX001, it announced on Wednesday.

United-states
Japan
Trademark-office
United-states-patent
Bivictrix-therapeutics
Bivictrix
Gets
Patent
Lead
Asset
Category-all

BiVictriX secures patent protection in Japan

BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF) said the Japanese Patent Office has granted a key patent for its lead anti-cancer drug, BVX001,.

United-states
Japan
Japanese
Japanese-patent-office
Trademark-office
Bivictrix-therapeutics
United-states-patent

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.